Moderating Growth RateGrowth appears to be moderating relative to the company’s earlier high-growth phase, reducing the pace of top-line expansion. Slower revenue acceleration makes sustaining margin expansion and ROIC more dependent on execution, pricing, and cross-sell, raising long-term growth risk if not addressed.
Inconsistent Cash ConversionOperating cash flow has lagged net income in several years (2025 OCF ~0.83x net income) and free cash flow dipped in 2022, signalling working-capital or timing variability. This inconsistency can constrain reinvestment, increase reliance on external financing, and complicate capital planning over the medium term.
Unclear Equity Step-changeAn unexplained step-change in equity between 2024 and 2025 may indicate dilution or other balance-sheet actions. Such moves can create uncertainty around capital allocation, shareholder dilution, and future EPS trends, affecting long-term investor returns and governance clarity.